Time-course Study of the Immunotoxic Effects of the Anticancer Drug Chlorambucil in the Rat

Toxicologic Pathology

Volumn 37, Issue 7, 2009, Pages 887-901

  Pearse, Gail ^a   Pietersma, Anne ^a   Cunliffe, jo ^a   Foster, John R ^a   Turton, John ^b   Derbyshire, Nicola ^a   Randall, Kevin J ^a  

^a ASTRAZENECA   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

bone marrow; chlorambucil; immunosuppression; immunotoxicity; lymphoid organs; rat

Indexed keywords

CHLORAMBUCIL; IMMUNOSUPPRESSIVE AGENT;

ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; BONE MARROW BIOPSY; CANCER SUSCEPTIBILITY; CELL POPULATION; CONTROLLED STUDY; CYTOLOGY; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTOXICITY; LYMPHOID CELL; LYMPHOID TISSUE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; RAT; THYMUS; WEIGHT CHANGE; WISTAR RAT;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; BODY WEIGHT; BONE MARROW; CHLORAMBUCIL; FEMALE; IMMUNOTOXINS; KINETICS; LYMPH NODES; LYMPHOCYTES; MODELS, ANIMAL; ORGAN SIZE; RATS; RATS, WISTAR; SPLEEN; THYMUS GLAND; TIME;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 74949139380     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1177/0192623309347907     Document Type: Article

References (27)

1. British National Formulary (BNF) 2007 London British Medical Association and the Pharmaceutical Society of Great Britain
2. Descotes J Methods of evaluating immunotoxicity Expert Opin Drug Metab Toxicol 2006 2 249 59
3. Dollery C Therapeutic Drugs 1999 Edinburgh Churchill Livingstone
4. Elson LA Galton DAG Till N The action of chlorambucil (CB 1348) and busulphan (Myeleran) on the haemopoietic organs of the rat Br J Haematol 1958 4 355 75
5. Gasper PW Feldman BF Zinkl JG Jain NC The hematopoietic system Vetrinary hematology 2000 Philadelphia Lippincott Williams and Wilkins 63 78
6. Gauthier B Trachtman H Pharmacological treatment of nephrotic syndrome Drugs Today 1999 35 13 26
7. Germolec DR Nyska A Kashon M Kuper CF Portier C Kommineni C Jonson KA Luster MI Extended histopathology in immunotoxicity testing: Interlaboratory validation studies Toxicol Sci 2004 78 107 15
8. Haley PJ Species differences in the structure and function of the immune system Toxicology 2003 188 49 71
9. Haley P Perry R Ennulat D Frame S Johnson C Lapointe JM Nyska A Snyder PW Walker D Walter G STP position paper: Best practice guideline for the routine pathology evaluation of the immune system Toxicol Pathol 2005 33 404 7
10. Hegab S Al-Mutawa S Immunopathogenesis of Behcet’s disease Clin Immunol 2000 96 174 86
11. Home Office Code of practice for the housing and care of animals used in scientific procedures 1989 London Her Majesty’s Stationary Office
12. International Conference On Harmonisation (ICH) Harmonised tripartite guideline: Immunotoxicity studies for human pharmaceuticals S8 2005 Available at http://www.ich.org/LOB/media/MEDIA1706.pdf
13. Kuper CF Schuurman H-J Vos JG Burleson GR Dean JH Munson AE Pathology in immunotoxicology Methods in immunotoxicology 1995 New York Wiley-Liss 397 436
14. Kuper CF Harleman JH Richter-Reichhelm HB Vos JG Histopathologic approaches to detect changes indicative of immunotoxicity Toxicol Pathol 2000 28 454 66
15. Kuper CF deHeer E Van Loveren H Vox JG Haschek W Rousseaux CG Wallig MA Immune system Handbook of toxicological pathology 2002 San Diego, CA Academic Press 585 646
16. Laharrague P Casteilla L Fantuzzi G Mazzone T Bone marrow adipose tissue Adipose tissue and adipokines in health and disease 2007 Totowa, NJ Humana Press 161 80
17. Maronpot RR A monograph on histomorphic evaluation of lymphoid organs Toxicol Pathol 2006 34 407 8
18. Medicines compendium 2002 London Datapharm Communications
19. Meyer DJ Harvey JW Veterinary laboratory medicine: interpretation and diagnosis 1998 Philidelphia, PA W. B. Saunders
20. Molyneux G Rizzo S Gibson FM Sulsh S Andrews CM Pilling AM Nakshbandi T Gordon-Smith EC Turton JA Haemotoxicity of chlorambucil in the Wistar Hanover rat with particular reference to bone marrow culture, marrow cell apoptosis and levels of FLT3 ligand Comp Clin Path 2004 13 70 81
21. Nath CE Shaw PJ Busulphan in blood and marrow transplantation: Dose, route, frequency and role of therapeutic drug monitoring Curr Clin Pharmacol 2007 2 75 91
22. Parfitt K Martindale: The extra pharmacopoeia 1999 32nd ed London Pharmaceutical Press
23. Reynolds JEF Martindale: The extra pharmacopoeia 1993 30th ed London Pharmaceutical Press
24. Rudd P Fries JF Epstein WV Irreversible bone marrow failure with chlorambucil J Rheumatol 1975 2 421 29
25. Saad A Palm M Widell S Reiland S Differential analysis of rat bone marrow by flow cytometry Comp Haematol Int 2001 10 97 101
26. Sweetman SC Martindale: The complete drug reference 2002 33rd ed London Pharmaceutical Press
27. Turton JA Sones WR Andrews CM Pilling AM Williams TC Molyneux G Rizzo S Gordon-Smith EC Gibson FM Further development of a model of chronic bone marrow aplasia in the busulphan-treated mouse Int J Exp Path 2006 87 49 63